ReShape Lifesciences(TM) Awarded Phase I NIH SBIR Grant to Further Develop Proprietary Diabetes Bloc-Stim Neuromodulation(TM) Device PressReach · Sep 23, 2022
GSK and Spero Therapeutics Announce Exclusive License Agreement for Late-Stage Antibiotic Asset, Tebipenem HBr PressReach · Sep 22, 2022
Tonix Pharmaceuticals Presents Data from Retrospective Observational Database Study on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients at IASP 2022 World Congress on Pain PressReach · Sep 22, 2022
The Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery PressReach · Sep 22, 2022
CVS Health reports progress against goal to reduce suicide attempts among Aetna members 20% by 2025 PressReach · Sep 22, 2022
Evoke Pharma Receives Notice of Allowance from USPTO for a Patent Related to GIMOTI PressReach · Sep 21, 2022
The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test PressReach · Sep 21, 2022
John Hancock becomes the first life insurance carrier to offer access to GRAIL's multi-cancer early detection test to customers PressReach · Sep 21, 2022
Stryker receives FDA clearance for OptaBlate(TM) Bone Tumor Ablation System PressReach · Sep 21, 2022
Health Canada approves Takeda's LIVTENCITY(TM) (maribavir) the First and Only Treatment for Adults with Post-Transplant Cytomegalovirus (CMV) infection PressReach · Sep 21, 2022